-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Viking Therapeutics, Raises Price Target to $87

Benzinga·09/23/2026 16:22:02
Diffusion vocale
Truist Securities analyst Joon Lee maintains Viking Therapeutics (NASDAQ:VKTX) with a Buy and raises the price target from $83 to $87.